fig2
Figure 2. Microscopic observation of the general skin morphology on Day 8 (D8) after injection. Improvement of the relief of the dermal-epidermal junction (DEJ) was observed with the 2.6% H-HA/3.2% sorbitol and 1.6% L-HA + 1.6% H-HA compositions, as compared with the control. The blue dotted line represents the DEJ.
